Drug use during pregnancy in Sweden – assessed by the Prescribed Drug Register and the Medical Birth Register
Authors:
- Olaf StephanssonOSOlaf Stephansson
- Tobias SvenssonTSTobias Svensson
- Bengt HaglundBHBengt Haglund
- Anders EkbomAEAnders Ekbom
- Helle KielerHKHelle Kieler
Open Access
- 1 February 2011
- journal article
- research article
- Published by Taylor & Francis in Clinical Epidemiology
- Vol. 3 (1) , 43-50
Abstract
Purpose: The purpose of this research is to study drug use during pregnancy in Sweden and agreement between use according to antenatal medical records and dispensed drugs from a pharmacy database. Patients and methods: From the Swedish Medical Birth Register (MBR), we established a population-based cohort of 102,995 women who gave birth in 2007. Using the unique personal registration number, information on dispensed drugs from the Prescribed Drug Register (PDR) was obtained prior to, during, and after the pregnancies and compared with MBR information on drug use from standardized antenatal medical records. Results: According to the PDR, 57.6% of the 102,995 women filled a prescription with at least one drug during pregnancy and 50.9% during the lactating period (until 3 months after delivery). The most dispensed drugs during pregnancy were B-lactam antibacterials and penicillins. Agreement between drugs recorded in antenatal medical records and dispensed drugs was highest for drugs used for chronic conditions. The agreement was particularly high for thyroid therapy (85.3%), anti-intestinal inflammatory drugs (80.3%), antiepileptics (69.2%), immunosuppressants (67.4%), and insulin (63.8%). Agreement for drugs used for occasional use was generally lower, ranging between 42.5% for antihistamines and 0.8% for gynecological anti-infectives. Conclusions: A large proportion of women filled a prescription during pregnancy or the lactating period. Agreement between drug use in medical antenatal records and register information from a national pharmacy database was high for drugs used for chronic conditions but low for occasional use. For occasionally used drugs, medical record and register-based data may provide incomplete exposure information because of nonreporting or noncompliance.Keywords
This publication has 26 references indexed in Scilit:
- Maternal schizophrenia and pregnancy outcome: Does the use of antipsychotics make a difference?Schizophrenia Research, 2010
- Prescription of drugs during pregnancy: a study using EFEMERIS, the new French databaseEuropean Journal of Clinical Pharmacology, 2009
- Prescription drug use among fathers and mothers before and during pregnancy. A population‐based cohort study of 106 000 pregnancies in Norway 2004–2006British Journal of Clinical Pharmacology, 2008
- Fertility and pregnancy in the patient with inflammatory bowel diseaseGut, 2006
- National patterns of medication use during pregnancyPharmacoepidemiology and Drug Safety, 2006
- Methodological issues in the epidemiological study of the teratogenicity of drugsCongenital Anomalies, 2005
- Antenatal steroids and the developing brainArchives of Disease in Childhood - Fetal and Neonatal Edition, 2000
- Drug use in first pregnancy and lactation: a population-based survey among Danish womenEuropean Journal of Clinical Pharmacology, 1999
- Drug use in pregnancy: A comparative appraisal of data collecting methodsEuropean Journal of Clinical Pharmacology, 1993
- Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. HippocampusDevelopmental Brain Research, 1990